The Vasoreparative Function of Myeloid Angiogenic Cells Is Impaired in Diabetes Through the Induction of IL1β

Myeloid angiogenic cells (MACs) promote revascularization through the paracrine release of angiogenic factors and have been harnessed as therapeutic cells for many ischemic diseases. However, their proangiogenic properties have been suggested to be diminished in diabetes. This study investigates how...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stem Cells
Main Authors: Chambers, Sarah E. J., O'Neill, Christina L., Guduric‐Fuchs, Jasenka, McLoughlin, Kiran J., Liew, Aaron, Egan, Aoife M., O'Brien, Timothy, Stitt, Alan W., Medina, Reinhold J.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Regenerative Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6001623/
https://ncbi.nlm.nih.gov/pubmed/29484768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/stem.2810
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados